GyroStim treatment is based on methodical, data-driven, incremental advancement that ensures optimal stimulation intensity is applied while protecting the individual from over-stimulation. The result is treatment sessions that are individualized, optimized, well-tolerated, efficient, and effective.
UltraThera Technologies, the maker of GyroStim, collaborated with research scientists at the Defense and Veterans Brain Injury Center (DVBIC) and US Army researchers at Ft. Carson, Colorado, in the development of a data-driven methodology for using GyroStim to improve the functional performance of the sensorimotor system.
The collaboration resulted in a flow chart expression of the strategic run-to-run progression strategy that utilizes subjective data and objective data for clinical decision support (CDS). This data-driven approach is highly effective, easily disseminated, and is the leading strategy for clinical applications.